|
| |
| | | 62061 | | 06.05.2011 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.40. | | | | 07.16.40. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Votubia 2.5 mg | Tabletten | Tablets (Everolimus 2.5 mg) | L01XE10 | CI | | 02 | Votubia 5 mg | Tabletten | Tablets (Everolimus 5 mg) | L01XE10 | CI | | 03 | Votubia 10 mg | Tabletten | Tablets (Everolimus 10 mg) | L01XE10 | CI |
|
|
|
